It has long been known that HIV infection increases an individual’s risk for certain types of cancer such as Non-Hodgkin lymphoma, Karposi’s sacroma, and cervical cancer. Preliminary research from a retrospective analysis of 5,357 patients withan average of 10.3 yearsof medical data suggests that HIV patients on a statin therapy had a 46% reduced risk of developing cancer compared to patients not on statin therapy. This preliminary research was presented at the International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention and has not yet been published in a peer-reviewed journal. This news may be a promising treatment for HIV patients to reduce their risk of HIV associated cancers, however only a randomized controlled clinical trial can confirm that statin therapy has a protective effect.How often do you see literature regarding common drugs for new indications? Have you ecently been surprised about use of an older medication for a new disease?
For additional information please click here MedPage Today